# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062822-25-000013
Filing Date
2025-03-07
Accepted
2025-03-07 16:02:54
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | lxrx-20241231.htm iXBRL | 10-K | 1468070
2 | EX-10.1 | exh101managementseveranc.htm | EX-10.1 | 41103
3 | EX-10.11 | exh1011stockoptionagreemen.htm | EX-10.11 | 30024
4 | EX-10.12 | exh1012restrictedstockunit.htm | EX-10.12 | 26741
5 | EX-10.15 | exh1015viatrisexclusivel.htm | EX-10.15 | 137167
6 | EX-19.1 | exh191insidertradingandc.htm | EX-19.1 | 20579
7 | EX-23.1 | exh231ernstyoungconsent2024.htm | EX-23.1 | 3482
8 | EX-31.1 | exh311certificationofprinc.htm | EX-31.1 | 11757
9 | EX-31.2 | exh312certificationofprinc.htm | EX-31.2 | 11617
10 | EX-32.1 | exh321certificationofprinc.htm | EX-32.1 | 7426
16 |  | exh1015viatrisexclusivel001.jpg | GRAPHIC | 864435
17 |  | exh1015viatrisexclusivel002.jpg | GRAPHIC | 895826
18 |  | exh1015viatrisexclusivel003.jpg | GRAPHIC | 1077955
19 |  | exh1015viatrisexclusivel004.jpg | GRAPHIC | 987753
20 |  | exh1015viatrisexclusivel005.jpg | GRAPHIC | 1116023
21 |  | exh1015viatrisexclusivel006.jpg | GRAPHIC | 961745
22 |  | exh1015viatrisexclusivel007.jpg | GRAPHIC | 1136826
23 |  | exh1015viatrisexclusivel008.jpg | GRAPHIC | 1178703
24 |  | exh1015viatrisexclusivel009.jpg | GRAPHIC | 949357
25 |  | exh1015viatrisexclusivel010.jpg | GRAPHIC | 368595
26 |  | exh1015viatrisexclusivel011.jpg | GRAPHIC | 725059
27 |  | exh1015viatrisexclusivel012.jpg | GRAPHIC | 241051
28 |  | exh101managementseveranc001.jpg | GRAPHIC | 894500
29 |  | exh101managementseveranc002.jpg | GRAPHIC | 926963
30 |  | exh101managementseveranc003.jpg | GRAPHIC | 1015292
31 |  | exh101managementseveranc004.jpg | GRAPHIC | 290434
32 |  | exh191insidertradingandc001.jpg | GRAPHIC | 832771
33 |  | exh191insidertradingandc002.jpg | GRAPHIC | 558007
34 |  | lxrx-20241231_g1.jpg | GRAPHIC | 90554
| Complete submission text file | 0001062822-25-000013.txt |  | 28544330

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lxrx-20241231.xsd | EX-101.SCH | 36173
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lxrx-20241231_cal.xml | EX-101.CAL | 74282
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lxrx-20241231_def.xml | EX-101.DEF | 228317
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lxrx-20241231_lab.xml | EX-101.LAB | 659218
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lxrx-20241231_pre.xml | EX-101.PRE | 456599
103 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrx-20241231_htm.xml | XML | 851356

Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30111 | Film No.: 25719921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)